MRK Merck & Co.
Performance
0% Past Week
Market Cap
267.9B
Day’s Range
52W Range
Volume (3M)
8.82M
Price-Earnings Ratio
18.47
Revenue
58.47B
Merck & Co. Latest News



About Merck & Co.
Merck Inc is a leading global healthcare company and is the main company of The Merck Group, a German multinational corporation headquartered in Darmstadt, Germany. The group was founded in 1668, making it the oldest pharmaceutical and chemical company in the world, and now includes around 250 companies in total, employing 57,000 people worldwide. The firm serves a global customer base, with a presence in 66 countries. The firm’s corporate headquarters are in Kenilworth, New Jersey.
Merck Inc. operates across multiple sectors, including healthcare, life sciences and performance materials. The firm’s healthcare innovations span many areas, such as endocrinology, oncology, fertility, general medicine, and neurodegenerative diseases. The firm also researches cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.
The firm offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Merck is also involved in the development of performance materials across various different sectors, such as architecture, functional solutions, semi-conductors and opto-electronics. The company went public in 1995, and trades on the NYSE where it is listed under the stock ticker MRK.
If you want to track the value of this company, simply add MRK stock to your eToro watchlist.
Show More69K
Employees
Kenilworth, New Jersey, US
HQ
1891
Founded
Robert M. Davis, MBA
CEO
Upcoming Earnings
27
APR
REPORTS
Merck & Co. Q1 2023 earnings report is expected to be released before market open
Consensus
Moderate Buy
Price Target
119.80
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
49
Medium
Industry
Avg. 47
63
Environment
60
Social
35
Governance
People Also Bought
- ABBV AbbVie Inc 0.45%
- GILD Gilead Sciences Inc 1.75%
- ABT Abbott Laboratories -1.37%
- LLY Eli Lilly & Co 0.91%
- BMY Bristol-Myers Squibb Co 0.19%
105.31